Immunohistochemical predictors of local recurrence in breast carcinoma: development and sensitivity validation of an IHC-based risk score
Romanian Journal of Morphology and Embryology · 10.03.2026 · 66 (4) · 645-652
DOI: 10.47162/rjme.66.4.02 ↗Kurz gefasst
Fachartikel in der Zeitschrift Romanian Journal of Morphology and Embryology, online erschienen am 03.03.2026. Verfasst von Valentina Căluianu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Medicine and Pharmacy of Craiova, Romania; laurentiu.barbu@umfcv.ro; gabriel.mogos@umfcv.ro. Hauptthemen laut MEDLINE: Breast Neoplasms, Neoplasm Recurrence, Local, Immunohistochemistry. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Local recurrence after breast-conserving surgery (BCS) remains clinically relevant and is associated with poorer long-term outcomes. While several prediction tools exist, many rely on costly genomic assays or omit key biological variables routinely assessed by immunohistochemistry (IHC). Patients, Materials and Methods: We retrospectively analyzed 100 consecutive patients with invasive breast carcinoma treated by BCS (2013–2018). IHC data included estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2/neu) [0–3+, with 2+ confirmed by chromogenic in situ hybridization (CISH)], as well as hormonal phenotypes. Local recurrence occurred in 21 cases. An integrated IHC score (0–6 points) was constructed using weighted biological predictors (ER-, PR-, HER2+, and ER-/PR- phenotype), stratifying cases into low (0–2), moderate (3–4), and high (≥5) risk categories. Although ER, PR, and HER2 status were available for all cases, case-level linkage between HER2 positivity and ER/PR phenotypes was not consistently available; therefore, three sensitivity scenarios (optimistic, neutral, and pessimistic) were applied to assess the robustness of the findings.
Results
Recurrence was higher in biologically unfavorable subgroups: ER- (26.47% vs. 9.09% in ER+), PR- (21.42% vs. 10.34% in PR+), ER-/PR- phenotype (37.5%), and HER2-positive tumors (33.33% vs. 11.36% in HER2-). The integrated score achieved consistent separation of risk categories, with most recurrences concentrated in moderate- and high-risk groups. Sensitivity analyses showed stable stratification across all three HER2 allocation scenarios, supporting the robustness of the model despite uncertainty in HER2- phenotype overlap.
Conclusions
A pragmatic IHC-based risk score based on routinely available biomarkers stratified local recurrence risk in breast cancer patients treated with BCS and remained stable under sensitivity testing. External validation in larger, multicenter cohorts is warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, University of Medicine and Pharmacy of Craiova, Romania; laurentiu.barbu@umfcv.ro; gabriel.mogos@umfcv.ro.
Zitieren
APA
Căluianu, V., Barbu, L. A., Mogoş, G. F. R., Mărgăritescu, N. D., Marinescu, D., Mogoantă, S. Ş., Vasile, L., Cercelaru, L., Ţenea-Cojan, I. A., & Ţenea-Cojan, T. Ş. (2026). Immunohistochemical predictors of local recurrence in breast carcinoma: development and sensitivity validation of an IHC-based risk score. Romanian Journal of Morphology and Embryology, 66(4), 645-652. https://doi.org/10.47162/rjme.66.4.02
Vancouver
Căluianu V, Barbu LA, Mogoş GFR, Mărgăritescu ND, Marinescu D, Mogoantă SŞ, et al. Immunohistochemical predictors of local recurrence in breast carcinoma: development and sensitivity validation of an IHC-based risk score. Romanian Journal of Morphology and Embryology. 2026;66(4):645-652. doi:10.47162/rjme.66.4.02
BibTeX
@article{Cluianu2026,
author = {Căluianu, Valentina and Barbu, Laurenţiu Augustus and Mogoş, Gabriel Florin Răzvan and Mărgăritescu, Nicolae Dragoş and Marinescu, Daniela and Mogoantă, Stelian Ştefăniţă and Vasile, Liviu and Cercelaru, Liliana and Ţenea-Cojan, Ioana Alexia and Ţenea-Cojan, Tiberiu Ştefăniţă},
title = {Immunohistochemical predictors of local recurrence in breast carcinoma: development and sensitivity validation of an IHC-based risk score},
journal = {Romanian Journal of Morphology and Embryology},
year = {2026},
volume = {66},
number = {4},
pages = {645--652},
doi = {10.47162/rjme.66.4.02}
}
EUVIMED